Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : VAX-001
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Covigenix VAX-001 encodes the SARS-CoV-2 Spike protein and uses novel Fusogenix technology for delivery. Using a NG-gene delivery technology to existing and approved mRNA vaccines, the VAX-001 DNA vaccine delivers the information needed inside cells to m...
Brand Name : VAX-001
Molecule Type : Vaccine
Upfront Cash : Not Applicable
April 16, 2021
Lead Product(s) : VAX-001
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?